The US Food and Drug Administration is going overboard with unwarranted requests that excipient and drug substance manufacturers test their materials for elemental impurities, according to a leading figure in the pharmaceutical excipients sector.
The International Council on Harmonisation’s Q3D guideline on elemental impurities only specifies that the drug product manufacturer submit this information, not suppliers, said Priscilla Zawislak,
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?